IMVT in the 13F filings
Immunovant Inc · CUSIP 45258J102
- Quarter end
- 30 Jun 2026
- the date the book describes
- Filed
- 2 Sep 2026
- latest of these filings; the earliest 3 Aug 2026
- Managers listing it
- 21
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q1 2026 and Q2 2026; 3 listed it in both
- Shares listed
- 30,074,288
- combined, among listed positions
- Reported value
- $1.2bn
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 15 buyers (opened or added shares) and 8 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +7,637,713.
Managers listing IMVT in Q2 2026
21 of 21 holders
Largest increases and reductions, by shares
Increases
- Farallon Capital Management LLCexisting position · 5,805,000 shares now+4,259,000
- T. Rowe Price Associates Incexisting position · 1,829,210 shares now+1,489,603
- D. E. Shaw & Co.new position · 1,240,654 shares now+1,240,654
- Renaissance Technologies LLCexisting position · 726,800 shares now+534,300
- Susquehanna International Group LLPexisting position · 1,022,513 shares now+404,706
Reductions
- Fidelity (FMR LLC)existing position · 16,186,469 shares now-761,419
- Marshall Wace LLPexisting position · 142,488 shares now-22,812
- Janus Henderson Group Ltdexisting position · 26,031 shares now-7,700
- Quantbot Technologies LPexisting position · 2,255 shares now-3,104
New positions and exits
New (6)
Exited (4)
- Jane Street Group LLCwas $2.1m
- Schonfeld Strategic Advisors LLCwas $833k
- ExodusPoint Capital Management LPwas $545k
- Hudson Bay Capital Management LPwas $478k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q4 2019 | 2 | $5.7m | n.a. | n.a. |
| Q1 2020 | 1 | $5.1m | n.a. | n.a. |
| Q2 2020 | 1 | $5.6m | n.a. | n.a. |
| Q3 2020 | 3 | $60m | n.a. | n.a. |
| Q4 2020 | 3 | $34m | n.a. | n.a. |
| Q1 2021 | 3 | $22m | n.a. | n.a. |
| Q2 2021 | 2 | $41m | n.a. | n.a. |
| Q3 2021 | 1 | $2.1m | n.a. | n.a. |
| Q4 2021 | 1 | $930k | n.a. | n.a. |
| Q1 2022 | 1 | $745k | n.a. | n.a. |
| Q3 2022 | 2 | $21m | n.a. | n.a. |
| Q4 2022 | 2 | $24m | n.a. | n.a. |
| Q1 2023 | 3 | $30m | n.a. | n.a. |
| Q2 2023 | 3 | $49m | n.a. | n.a. |
| Q3 2023 | 5 | $111m | n.a. | n.a. |
| Q4 2023 | 5 | $205m | 3 | 2 |
| Q1 2024 | 4 | $176m | 2 | 3 |
| Q2 2024 | 5 | $136m | 4 | 0 |
| Q3 2024 | 4 | $135m | 0 | 1 |
| Q4 2024 | 3 | $51m | 0 | 3 |
| Q1 2025 | 3 | $45m | 1 | 1 |
| Q2 2025 | 4 | $81m | 3 | 1 |
| Q3 2025 | 3 | $80m | 1 | 0 |
| Q4 2025 | 3 | $101m | 11 | 12 |
| Q1 2026 | 3 | $90m | 12 | 9 |
| Q2 2026 | 4 | $927m | 15 | 8 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
IMVT and GILD →IMVT and AMGN →IMVT and ARGX →Choose a stock to compare with IMVT →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own IMVT, latest filings →Back to the 13F Explorer →